Status:

COMPLETED

Adrenalectomy for Solitary Adrenal Gland Metastases

Lead Sponsor:

Mayo Clinic

Conditions:

Adrenal Gland Metastases

Adrenalectomy

Eligibility:

All Genders

Brief Summary

The adrenal glands are one of the most common organs involved in metastatic disease. Metastases are the second most common type of adrenal mass, second only to adenomas. It is a frequent finding durin...

Eligibility Criteria

Inclusion

  • Metastatic disease to the adrenal gland

Exclusion

  • Primary adrenal neoplasm

Key Trial Info

Start Date :

November 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2010

Estimated Enrollment :

168 Patients enrolled

Trial Details

Trial ID

NCT01135238

Start Date

November 1 2009

End Date

November 1 2010

Last Update

December 16 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Adrenalectomy for Solitary Adrenal Gland Metastases | DecenTrialz